Valproic Acid Toxicity: Overview and Management

REFERENCES

• Pinkston R., Walker L.A. Multiorgan System Failure Caused by Valproic Acid Toxicity. Am. J. Emerg. Med. 1997; 15: 504–506
   PubMed Web of Science ®Google Scholar
• Davis L.L., Ryan W., Adinoff B., Petty F. Comprehensive Review of the Psychiatric Uses of Valproate. J. Clin. Psychopharmacol. 2000; 20(Suppl. 1)1S–7S
   PubMed Web of Science ®Google Scholar
• Evans D.L. Bipolar Disorder: Diagnostic Challenges and Treatment Considerations. J. Clin. Psychiatry 2000; 61(Suppl. 13)26–31
   PubMed Web of Science ®Google Scholar
• Goldberg J.F. Treatment Guidelines: Current and Future Management of Bipolar Disorder. J. Clin. Psychiatry 2000; 61(Suppl. 13)12–18
   PubMedGoogle Scholar
• Nemeroff C.B. An Ever-Increasing Pharmacopoeia for the Management of Patients with Bipolar Disorder. J. Clin. Psychiatry 2000; 61(Suppl. 13)19–25
   PubMedGoogle Scholar
• Mathew N.T., Kailasam J., Meadors L., Chernyschev O., Gentry P. Intravenous Valproate Sodium (Depacon) Aborts Migraine Rapidly: A Preliminary Report. Headache 2000; 40: 720–723
   PubMed Web of Science ®Google Scholar
• Norton J. Use of Intravenous Valproate Sodium in Status Migraine. Headache 2000; 40: 755–757
   PubMed Web of Science ®Google Scholar
• Kinze S., Clauss M., Reuter U., Wolf T., Dreier J.P., Einhaupl K.M., Arnold G. Valproic Acid Is Effective in Migraine Prophylaxis at Low Serum Levels: A Prospective Open-Label Study. Headache 2001; 41: 774–778
   PubMed Web of Science ®Google Scholar
• Hardy J.R., Rees E.A.J., Gwilliam B., Ling J., Broadley K., A'Hern R. A Phase II Study to Establish the Efficacy and Toxicity of Sodium Valproate in Patients with Cancer-Related Neuropathic Pain. J. Pain Symptom Manag. 2001; 21: 204–209
   PubMed Web of Science ®Google Scholar
• Litovitz T.L., Klein-Schwartz W., White S., Cobaugh D.J., Youniss J., Omslaer J.C., Drab A., Benson B.E. 2000 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am. J. Emerg. Med. 2001; 19: 337–395
   PubMed Web of Science ®Google Scholar
• Litovitz T.L., Felberg L., White S., Klein-Schwartz W. 1995 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am. J. Emerg. Med. 1996; 14: 487–537
   PubMed Web of Science ®Google Scholar
• Litovitz T.L., Bailey K.M., Schmitz B.F., Holm K.C., Klein-Schwartz W. 1990 Annual Report of the American Association of Poison Control Centers National Data Collection System. Am. J. Emerg. Med. 1991; 9: 461–509
   PubMed Web of Science ®Google Scholar
• Klotz U., Antonin K.H. Pharmacokinetics and Bioavailability of Sodium Valproate. Clin. Pharmacol. Ther. 1977; 21: 736–743
   PubMed Web of Science ®Google Scholar
• Kandrotas R.J., Love J.M., Gal P., Oles K.S. The Effect of Hemodialysis and Hemoperfusion on Serum Valproic Acid Concentration. Neurology 1990; 40: 1456–1458
   PubMed Web of Science ®Google Scholar
• Nau H., Loscher W. Valproic Acid and Metabolites: Pharmacological and Toxicological Studies. Epilepsia 1984; 25(S1)S14–S22
   Google Scholar
• Kane S.L., Constantiner M., Staubus A.E., Meinecke C.D., Sedor J.R. High-Flux Hemodialysis Without Hemoperfusion Is Effective in Acute Valproic Acid Overdose. Ann. Pharmacother. 2000; 34: 1146–1151
   PubMed Web of Science ®Google Scholar
• Farrar H.C., Herold D.A., Reed M.D. Acute Valproic Acid Intoxication: Enhanced Drug Clearance with Oral-Activated Charcoal. Crit. Care Med. 1993; 21: 299–301
   PubMed Web of Science ®Google Scholar
• Al-Shareef A., Buss D.C., Shetty H.G.M., Ali N., Routledge P.A. The Effect of Repeated-Dose Activated Charcoal on the Pharmacokinetics of Sodium Valproate in Healthy Volunteers. Br. J. Clin. Pharmacol. 1997; 43: 109–111
   PubMed Web of Science ®Google Scholar
• Graudins A., Aaron C.K. Delayed Peak Serum Valproic Acid in Massive Divalproex Overdose—Treatment with Charcoal Hemoperfusion. J. Toxicol. Clin. Toxicol. 1996; 34: 335–341
   PubMed Web of Science ®Google Scholar
• Duarte J., Macias S., Coria F., Fernandez E., Claveria L.E. Valproate-Induced Coma: Case Report and Literature Review. Ann. Pharmacother. 1993; 27: 582–583
   PubMed Web of Science ®Google Scholar
• Tatsuhara T., Muro H., Matsuda Y., Imai Y. Determination of Valproic Acid and it Metabolites by Gas Chromatography–Mass Spectrometry with Selected Ion Monitoring. J. Chromatogr. 1987; 399: 183–195
   PubMed Web of Science ®Google Scholar
• Hamer H.M., Knake S., Schomburg M.A., Rosenow F. Valproate-Induced Hyperammonemic Encephalopathy in the Presence of Topiramate. Neurology 2000; 54: 230–232
   PubMed Web of Science ®Google Scholar
• Spiller H.A., Krenzelok E.P., Klein-Schwartz W., Winter M.L., Weber J.A., Sollee D.R., Bangh S.A., Griffith J.R. Multicenter Case Series of Valproic Acid Ingestion. J. Toxicol. Clin. Toxicol. 1999; 37: 637
   Google Scholar
• Ingels M., Johnson C., Rangan C., Cantrell L., Beauchamp J., Clark R.F. Retrospective Study of Delayed Valproic Acid Toxicity. Acad. Emerg. Med. 2000; 7: 499
   Google Scholar
• Franssen E.J., van Essen G.G., Portman A.T., de Jong J., Go G., Stegeman C.A., Uges D.R. Valproic Acid Toxicokinetics: Serial Hemodialysis and Hemoperfusion. Ther. Drug Monit. 1999; 21: 289–292
   PubMed Web of Science ®Google Scholar
• Dupuis R.E., Lichtman S.N., Pollack G.M. Acute Valproic Acid Overdose. Clinical Course and Pharmacokinetic Disposition of Valproic Acid and Metabolites. Drug Saf. 1990; 5: 65–71
   PubMed Web of Science ®Google Scholar
• Chadwick D.W. Concentration–Effect Relationships of Valproic Acid. Clin. Pharmacokinet. 1985; 10: 155–163
   PubMed Web of Science ®Google Scholar
• Andersen G., Ritland S. Life Threatening Intoxication with Sodium Valproate. J. Toxicol. Clin. Toxicol. 1995; 33: 279–284
   PubMed Web of Science ®Google Scholar
• Johnson L.Z., Martinez I., Fernandez M.C., Davis C.P., Kasinath B.S. Successful Treatment of Valproic Acid Overdose with Hemodialysis. Am. J. Kidney Dis. 1999; 33: 786–789
   PubMed Web of Science ®Google Scholar
• Mortensen P.B., Hansen H.E., Pedersen B., Hartmann-Andersen F., Husted S.E. Acute Valproate Intoxication: Biochemical Investigations and Hemodialysis Treatment. Int. J. Clin. Pharmacol. Ther. Toxicol. 1983; 21: 64–68
   PubMedGoogle Scholar
• Nau H., Wittfoht W. Valproic Acid and Several Metabolites: Quantitative Determination in Serum, Urine, Breast Milk, and Tissues by Gas Chromatography–Mass Spectrometry Using Selected Ion Monitoring. J. Chomatogr. 1981; 226: 69–78
   PubMed Web of Science ®Google Scholar
• Jakobs C., Loscher W. Identification of Metabolites of Valproic Acid in Serum of Humans, Dog, Rat, and Mouse. Epilepsia 1978; 19: 591–602
   PubMed Web of Science ®Google Scholar
• Cotariu D., Zaidman J.L. Valproic Acid and the Liver. Clin. Chem. 1988; 34(5)890–897
   PubMed Web of Science ®Google Scholar
• Raskind J.Y., El-Chaar G.M. The Role of Carnitine Supplementation During Valproic Acid Therapy. Ann. Pharmacother. 2000; 34: 630–638
   PubMed Web of Science ®Google Scholar
• Ishikura H., Matsuo N., Matsubara M., Ishihara T., Takeyama N., Tanaka T. Valproic Acid Overdose and l-Carnitine Therapy. J. Anal. Toxicol. 1996; 20: 55–58
   PubMed Web of Science ®Google Scholar
• Johannessen C.U. Mechanisms of Action of Valproate: A Commentatory. Neurochem. Int. 2000; 37: 103–110
   PubMed Web of Science ®Google Scholar
• McLean M.J., MacDonald R.L. Sodium Valproate, But Not Ethosuximide, Produces Use- and Voltage-Dependent Limitation of High Frequency Repetitive Firing of Action Potentials of Mouse Central Neurons in Cell Culture. J. Pharmacol. Exp. Ther. 1986; 237: 1001–1011
   PubMed Web of Science ®Google Scholar
• Farrant M., Webster R.A. Neuronal Activity, Amino Acid Concentration, and Amino Acid Release in the Substantia Nigra of the Rat After Sodium Valproate. Brain Res. 1986; 386: 1–11
   PubMedGoogle Scholar
• Albus H., Williamson R. Electrophysical Analysis of the Action of Valproate on Pyramidal Neurons in the Rat Hippocampal Slice. Epilepsia 1998; 39: 124–139
   PubMed Web of Science ®Google Scholar
• Hariton C., Ciesielski L., Simler S., Valli M., Jadot G., Gobaille S., Mesdjian E., Mandel P. Distribution of Sodium Valproate and GABA Metabolism in CNS of the Rat. Biopharm. Drug Dispos. 1984; 5: 409–414
   PubMed Web of Science ®Google Scholar
• Keane P.E., Simiand J., Morre M. Comparison of the Pharmacological and Biochemical Profiles of Valproic Acid (VPA) and Its Cerebral Metabolite (2-en-VPA) After Oral Administration in Mice. Methods Find. Exp. Clin. Pharmacol. 1985; 7: 83–86
   PubMed Web of Science ®Google Scholar
• Keane P.E., Morre M. Effect of Valproate on Brain GABA: Comparison with Various Medium Chain Fatty Acids. Pharmacol. Res. Commun. 1985; 17: 547–555
   PubMedGoogle Scholar
• Swann A.C. Major Systemic Toxicities and Side Effects of Anticonvulsants. J. Clin. Psychiatry 2001; 62(Suppl. 14)16–21
   PubMedGoogle Scholar
• Khoo S.H., Leyland M.J. Cerebral Edema Following Acute Sodium Valproate Overdose. J. Toxicol. Clin. Toxicol. 1992; 30: 209–214
   PubMed Web of Science ®Google Scholar
• Matsumoto J., Ogawa H., Maeyama R., Okudaira K., Shinka T., Kuhara T., Matsumoto I. Successful Treatment by Direct Hemoperfusion of Coma Possibly Resulting from Mitochondrial Dysfunction in Acute Valproate Intoxication. Epilepsia 1997; 38: 950–953
   PubMed Web of Science ®Google Scholar
• Triggs W.J., Gilmore R.L., Millington D.S., Cibula J., Bunch T.S., Harman E. Valproate-Associated Carnitine Deficiency and Malignant Cerebral Edema in the Absence of Hepatic Failure. Int. J. Clin. Pharmacol. Ther. 1997; 35: 353–356
   PubMed Web of Science ®Google Scholar
• Janssen F., Rambeck B., Schnabel R. Acute Valproate Intoxication with Fatal Outcome in an Infant. Neuropediatrics 1985; 16: 235–238
   PubMed Web of Science ®Google Scholar
• Berthelot-Moritz F., Chadda K., Chanavaz I., Leroy J.P., Droy J.M., Bonmarchand G., Leroy J. Fatal Sodium Valproate Poisoning. Intensive Care Med. 1997; 23: 599
   PubMed Web of Science ®Google Scholar
• Loscher W., Nau H. Pharmacological Evaluation of Various Metabolites and Analogues of Valproic Acid. Anticonvulsant and Toxic Potencies in Mice. Neuropharmacology 1985; 24: 427–435
   PubMed Web of Science ®Google Scholar
• Murakami K., Sugimoto T., Woo M., Nishida N., Muro H. Effect of l-Carnitine Supplementation on Acute Valproate Intoxication. Epilepsia 1996; 37: 687–689
   PubMed Web of Science ®Google Scholar
• Blei A.T. Pathophysiology of Brain Edema in Fulminant Hepatic Failure, Revisited. Metab. Brain Dis. 2001; 16: 85–94
   PubMed Web of Science ®Google Scholar
• Albrecht J., Dolinska M. Glutamine as a Pathogenic Factor in Hepatic Encephalopathy. J. Neurosci. Res. 2001; 65: 1–5
   PubMed Web of Science ®Google Scholar
• Hertz L., Yu A.C.H., Kala G., Schousboe A. Neuronal-Astrocytic and Cytosolic-Mitochondrial Metabolite Trafficking During Brain Activation, Hyperammonemia, and Energy Deprivation. Neurochem. Int. 2000; 37: 83–102
   PubMed Web of Science ®Google Scholar
• Marcaida G., Felipo V., Hermenegildo C., Minana M.D., Grisolia S. Acute Ammonia Toxicity Is Mediated by the NMDA Type of Glutamate Receptors. FEBS Lett. 1992; 13(296)67–68
   Google Scholar
• Connacher A.A., MacNab M.S., Moody J.P., Jung R.T. Fatality Due to Massive Overdose of Sodium Valproate. Scott. Med. J. 1987; 32: 85–86
   PubMed Web of Science ®Google Scholar
• Camfield P.R., Bagnell P., Camfield C.S., Tibbles J.A. Pancreatitis Due to Valproic Acid. Lancet 1979; 1: 1198–1199
   PubMed Web of Science ®Google Scholar
• Batalden P.B., Van Dyne B.J., Cloyd J. Pancreatitis Associated with Valproic Acid Therapy. Pediatrics 1979; 64: 520–522
   PubMed Web of Science ®Google Scholar
• Binek J., Hany A., Heer M. Valproic-Acid-Induced Pancreatitis: Case Report and Review of the Literature. J. Clin. Gastroenterol. 1991; 3: 690–693
   Google Scholar
• Rosenberg H.K., Ortega W. Hemorrhagic Pancreatitis in a Young Child Following Valproic Acid Therapy. Clin. Pediatr. 1987; 26: 98–101
   PubMed Web of Science ®Google Scholar
• Caparros-Lefebvre D., Lecomte-Houcke M., Pruvot F.R., Declerck N., Paris J.C., Petit H. Unusual Electronmicroscopic Changes in Valproate-Associated Liver Failure. Lancet 1993; 341: 1604
   PubMed Web of Science ®Google Scholar
• Gerber N., Dickinson R.G., Harland R.C., Lynn R.K., Houghton L.D., Antonias J.I., Schimschock J.C. Reye-like Syndrome Associated with Valproic Acid Therapy. J. Pediatr. 1979; 95: 142–144
   PubMed Web of Science ®Google Scholar
• Suchy F.J., Balistreri W.F., Buchino J.J., Sondheimer J.M., Bates S.R., Kearns G.L., Stull J.D., Bove K.E. Acute Hepatic Failure Associated with the Use of Sodium Valproate. N. Engl. J. Med. 1979; 300: 962–966
   PubMed Web of Science ®Google Scholar
• Appleton R.E., Farrell K., Applegarth D.A., Dimmick J.E., Wong L.T., Davidson A.G. The High Incidence of Valproate Hepatotoxicity in Infants May Relate to Familial Metabolic Defects. Can. J. Neurol. Sci. 1990; 17: 145–148
   PubMed Web of Science ®Google Scholar
• Krahenbuhl S., Brandner S., Kleinle S., Liechti S., Straumann D. Mitochondrial Diseases Represent a Risk Factor for Valproate-Induced Fulminant Liver Failure. Liver 2000; 20: 346–348
   PubMedGoogle Scholar
• Chabrol B., Mancini J., Chretien D., Rustin P., Munnich A., Pinsard N. Valproate-Induced Hepatic Failure in a Case of Cytochrome C Oxidase Deficiency. Eur. J. Pediatr. 1994; 153: 133–135
   PubMed Web of Science ®Google Scholar
• Kochen W., Schneider A., Ritz A. Abnormal Metabolism of Valproic Acid in Fatal Hepatic Failure. Eur. J. Pediatr. 1983; 141: 30–35
   PubMed Web of Science ®Google Scholar
• Kuhara T., Inoue Y., Matsumoto M., Shinka T., Matsumoto I., Kawahara N., Sakura N. Markedly Increased ω-Oxidation of Valproate in Fulminant Hepatic Failure. Epilepsia 1990; 31: 214–217
   PubMed Web of Science ®Google Scholar
• Kesterson J.W., Granneman G.R., Machinist J.M. The Hepatotoxicity of Valproic Acid and Its Metabolites in Rats. I. Toxicologic, Biochemical and Histopathologic Studies. Hepatology 1984; 4: 1143–1152
   PubMed Web of Science ®Google Scholar
• Rettie A.E., Rettenmeier A.W., Howald W.N., Baillie T.A. Cytochrome P-450-Catalyzed Formation of Delta 4-VPA, a Toxic Metabolite of Valproic Acid. Science 1987; 235: 890–893
   PubMed Web of Science ®Google Scholar
• Kulick S.K., Kramer D.A. Hyperammonemia Secondary to Valproic Acid as a Cause of Lethargy in a Postictal Patient. Ann. Emerg. Med. 1993; 22: 610–612
   PubMed Web of Science ®Google Scholar
• Thabet H., Brahmi N., Amamou M., Ben Salah N., Hedhili N. Hyperlactatemia and Hyperammonemia as Secondary Effects of Valproic Acid Poisoning. Am. J. Emerg. Med. 2000; 18: 508
   PubMed Web of Science ®Google Scholar
• Lee W.L., Yang C.C., Deng J.F., Chen Y.F., Lin H.D., Wang P.H. A Case of Severe Hyperammonemia and Unconsciousness Following Sodium Valproate Intoxication. Vet. Hum. Toxicol. 1998; 40: 346–348
   PubMedGoogle Scholar
• Hjelm M., Oberholzer V., Seakins J., Thomas S., Kay J.D.S. Valproate-Induced Inhibition of Urea Synthesis and Hyperammonaemia in Healthy Subjects. Lancet 1986; 2: 859
   PubMed Web of Science ®Google Scholar
• Rawat S., Borkowski W.J., Swick H.M. Valproic Acid and Secondary Hyperammonemia. Neurology 1981; 31: 1173–1174
   PubMed Web of Science ®Google Scholar
• Coulter D.L. Carnitine Deficiency in Epilepsy: Risk Factors and Treatment. J. Child Neurol. 1995; 10(Suppl. 2)S32–S39
   Google Scholar
• Rumbach L., Cremel G., Marescaux C., Warter J.M., Waksman A. Valproate-Induced Hyperammonemia of Renal Origin. Effect of Valproate on Glutamine Transport in Rat Kidney Mitochondria. Biochem. Pharmacol. 1989; 38: 3963–3967
   PubMed Web of Science ®Google Scholar
• Coulter D.L., Allen R.J. Secondary Hyperammonemia: A Possible Mechanism for Valproate Encephalopathy. Lancet 1980; 1310–1311
   PubMed Web of Science ®Google Scholar
• Coude F.X., Rabier D., Cathelineau L., Grimber G., Parvy P., Kamoun P.P. A Mechanism for Valproate-Induced Hyperammonemia. Pediatr. Res. 1981; 15: 974–975
   PubMed Web of Science ®Google Scholar
• Paganini M., Zaccara G., Moroni F. Lack of Relationship Between Sodium Valproate-Induced Adverse Effects and the Plasma Concentration of Its Metabolite 2-Propylpenten-4-oic Acid. Eur. J. Clin. Pharmacol. 1987; 32: 219–222
   PubMed Web of Science ®Google Scholar
• Kondo T., Ishida M., Kaneko S., Hirano T., Otani K., Fukushima Y., Muranaka H., Koide N., Yokoyama M., Nakata S., Kudo H. Is 2-Propyl-4-pentenoic acid, a Hepatotoxic Metabolite of Valproate, Responsible for Valproate-Induced Hyperammonemia?. Epilepsia 1992; 33: 550–554
   PubMed Web of Science ®Google Scholar
• Dreifuss F.E., Santilli N., Langer D.H., Sweeney K.P., Moline K.A., Menander K.B. Valproic Acid Hepatic Fatalities: A Retrospective Review. Neurology 1987; 37: 379–385
   PubMed Web of Science ®Google Scholar
• Murakami K., Sugimoto T., Nishida N., Kobayashi Y., Kuhura T., Matsumoto I. Abnormal Metabolism of Carnitine and Valproate in a Case of Acute Encephalopathy During Chronic Valproate Therapy. Brain Dev. 1992; 14: 178–181
   PubMed Web of Science ®Google Scholar
• Beversdorf D., Allen C., Nordgren R. Valproate-Induced Encephalopathy Treated with Carnitine in an Adult. J. Neurol. Neurosurg. Psychiatry 1996; 61: 211
   PubMed Web of Science ®Google Scholar
• De Vivo D.C., Bohan T.P., Coulter D.L., Dreifuss F.E., Greenwood R.S., Nordli D.R., Shields W.D., Stafstrom C.E., Tein I. l-Carnitine Supplementation in Childhood Epilepsy: Current Perspectives. Epilepsia 1998; 39: 1216–1225
   PubMed Web of Science ®Google Scholar
• Coulter D.L. Carnitine, Valproate and Toxicity. J. Child Neurol. 1991; 6: 7–14
   PubMed Web of Science ®Google Scholar
• Thom H., Carter P.E., Cole G.F., Stevenson K.L. Ammonia and Carnitine Concentrations in Children Treated with Sodium Valproate Compared with Other Anticonvulsant Drugs. Dev. Med. Child Neurol. 1991; 33: 795–802
   PubMed Web of Science ®Google Scholar
• Takeuchi T., Sugimoto T., Nishida N., Kobayashi Y. Protective Effect of d,l-Carnitine on Valproate-Induced Hyperammonemia and Hypoketonemia in Primary Cultured Rat Hepatocytes. Biochem. Pharmacol. 1988; 37: 2255–2258
   PubMed Web of Science ®Google Scholar
• Ponchaut S., van Hoof F., Veitch K. In Vitro Effects of Valproate and Valproate Metabolites on Mitochondrial Oxidations. Relevance of CoA Sequestration to the Observed Inhibitions. Biochem. Pharmacol. 1992; 43: 2435–2442
   PubMed Web of Science ®Google Scholar
• Baldwin G.S., Abbott F.S., Nau H. Binding of a Valproate Metabolite to the Trifunctional Protein of Fatty Acid Oxidation. FEBS Lett. 1996; 384: 58–60
   PubMed Web of Science ®Google Scholar
• Alonso E., Girbes J., Garcia-Espana A., Rubio V. Changes in Urea Cycle-Related Metabolites in the Mouse After Combined Administration of Valproic Acid and an Amino Acid Load. Arch. Biochem. Biophys. 1989; 272: 267–273
   PubMed Web of Science ®Google Scholar
• Thurston J.H., Carroll J.E., Hauhart R.E., Schiro J.A. A Single Therapeutic Dose of Valproate Affects Liver Carbohydrate, Fat, Adenylate, Amino Acid, Coenzyme A, and Carnitine Metabolism in Infant Mice: Possible Clinical Significance. Life Sci. 1985; 36: 1643–1651
   PubMed Web of Science ®Google Scholar
• Beauchamp J., Olson K. Valproic Acid Overdoses: A Retrospective Study Comparing Serum Drug Levels and the Incidence of Adverse Outcomes. J. Toxicol. Clin. Toxicol. 1999; 37: 637–638
   Google Scholar
• Roodhooft A.M., Van Dam K., Haentjens D., Verpooten G.A., Van Acker K.J. Acute Sodium Valproate Intoxication: Occurrence of Renal Failure and Treatment with Haemoperfusion–Haemodialysis. Eur. J. Pediatr. 1990; 149: 363–364
   PubMed Web of Science ®Google Scholar
• Settle E.J., Jr. Valproic Acid-Associated Encephalopathy with Coma. Am. J. Psychiatr. 1995; 152: 1236–1237
   PubMed Web of Science ®Google Scholar
• Barrueto F., Jr., Hack J.B. Hyperammonemia and Coma Without Hepatic Dysfunction Induced by Valproate Therapy. Acad. Emerg. Med. 2001; 8: 999–1001
   PubMed Web of Science ®Google Scholar
• Chyka P.A., Seger D. Position Statement: Single-Dose Activated Charcoal. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J. Toxicol. Clin. Toxicol. 1997; 35: 721–741
   PubMed Web of Science ®Google Scholar
• Anon. Position Statement and Practice Guidelines on the Use of Multi-dose Activated Charcoal in the Treatment of Acute Poisoning. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J. Toxicol. Clin. Toxicol. 1999; 37: 731–751
   PubMedGoogle Scholar
• Von Bardeleben R.S., Sturer A., Weilemann L.S. Valproic Acid Intoxications in 96 Documented Cases 1995–1998: The Role of Hemoperfusion in Therapy. J. Toxicol. Clin. Toxicol. 1998; 36: 471–472
   Google Scholar
• Matsumoto J., Ogawa H., Maeyama R., Okudaira K., Shinka T., Kuhara T., Matsumoto I. Successful Treatment by Direct Hemoperfusion of Coma Possibly Resulting from Mitochondrial Dysfunction in Acute Valproate Intoxication. Epilepsia 1997; 38: 950–953
   PubMed Web of Science ®Google Scholar
• Tank J.E., Palmer B.F. Simultaneous “In Series” Hemodialysis and Hemoperfusion in the Management of Valproic Acid Overdose. Am. J. Kidney Dis. 1993; 22: 341–344
   PubMed Web of Science ®Google Scholar
• Ruskoky D., Holmes C., Schauben J. Utilization of Hemodialysis to Enhance Valproic Acid (VPA) Elimination. J. Toxicol. Clin. Toxicol. 1999; 37: 636
   Google Scholar
• Graeme K., Higgins T., Curry S., Kunkel D. Markedly Elevated Valproate Levels Do Not Serve as an Indication for Hemodialysis or Hemoperfusion. J. Toxicol. Clin. Toxicol. 1999; 37: 636
   Google Scholar
• Steiman G.S., Woerpel R.W., Sherard E.S., Jr. Treatment of Accidental Sodium Valproate Overdose with an Opiate Antagonist. Ann. Neurol. 1979; 6: 274
   PubMed Web of Science ®Google Scholar
• Alberto G., Erickson T., Popiel R., Narayanan M., Hryhorczuk D. Central Nervous System Manifestations of a Valproic Acid Overdose Responsive to Naloxone. Ann. Emerg. Med. 1989; 18: 889–891
   PubMed Web of Science ®Google Scholar
• Montero F.J. Naloxone in the Reversal of Coma Induced by Sodium Valproate. Ann. Emerg. Med. 1999; 33: 357–358
   PubMed Web of Science ®Google Scholar
• Espinoza O., Maradei I., Ramirez M., Pascuzzo-Lima C. An Unusual Presentation of Opioid-like Syndrome in Pediatric Valproic Acid Poisoning. Vet. Hum. Toxicol. 2001; 43: 178–179
   PubMedGoogle Scholar
• Takeuchi T., Sugimoto T., Nishida N., Kobayashi Y. Protective Effect of d,l-Carnitine on Valproate-Induced Hyperammonemia and Hypoketonemia in Primary Cultured Rat Hepatocytes. Biochem. Pharmacol. 1988; 37: 2255–2258
   PubMed Web of Science ®Google Scholar
• Anon. Carnitor. Physician's Desk Reference. 54th Ed., Medical Economic Company, Montvale, NJ 2000
   Google Scholar
• Sztajnkrycer M.D., Seaglione J.M., Bond G.R. Valproate-Induced Hyperammonemia: Preliminary Evaluation of Ammonia Elimination with Carnitine Administration. J. Toxicol. Clin. Toxicol. 2001; 39: 497
   Google Scholar
• Thole D., Bagnasco T., Lovecchio F. Delayed Absorption of Valproic Acid Resulting in Coma. J. Toxicol. Clin. Toxicol. 2001; 39: 497
   Google Scholar